Search results

  1. V.R.T.

    ME/CFS Science Blog article - Immune findings in ME/CFS

    No need to apologise (or to have deleted it), I got a bit worked up and maybe posted on the attack. I understand that your fear and pessimism is genuinely felt. I was a very pessimistic person before this and in many ways still am so perhaps I find it harder than most to ignore statements like...
  2. V.R.T.

    ME/CFS Science Blog article - Immune findings in ME/CFS

    I am getting really sick of the pessimism that keeps being trotted out over and over again every single time anyone offers the faintest glimmer of hope. Our grandchildren? We have researchers and clicnians on here most days saying that there is hope for a breakthrough soon and it's met with...
  3. V.R.T.

    United Kingdom: ME Association news

    From MECFS patients Gaul Parner and Malistair Ailler.
  4. V.R.T.

    ME/CFS Science Blog article - Immune findings in ME/CFS

    I've gotten the distinct impression over the last year or so that the researchers and clinicians on this forum are not nearly so pessimistic. There is a lot of talk about how a breakthrough could happen soon. But I don't need to tell you that at this point. I think there's a middle ground...
  5. V.R.T.

    ME/CFS Science Blog article - Immune findings in ME/CFS

    This is a huge problem for the MECFS and LC communities and I think articles like this are the best way to address it. Wirth in particular presents his speculations as fact when he has done no basic research or clinical trials which is very problematic. They do fund some good research but yes I...
  6. V.R.T.

    Open [USA] A Double-blind, Randomized Study to Evaluate the Efficacy and Safety of Bezisterim (NE3107) in Adults With Long COVID [ADDRESS-LC]

    So this reports in like 6 months! I'd forgotten about it tbh, and how fast they're moving. So it works on TLR pathways, not clear which from this - could be interesting to know if this has an effect.
  7. V.R.T.

    SequenceME genetic study - from Oxford Nanopore Technologies, the University of Edinburgh and Action for ME

    Do we have estimations of how long SequenceME and Long Covid will take? I think someone estimated 18 months when it was first announced but that was when it was just going to be the analysis of DecodeME samples iirc. Obviously the LC collection phase will take longer. If the project is...
  8. V.R.T.

    USA: Mount Sinai PACS clinic and Dr David Putrino

    Why is it that people who flog poorly evidenced treatments always go on about there not being magic bullets, like that makes their poorly evidenced treatment more appealing?
  9. V.R.T.

    Needing to lie flat

    Also when you're severe ignoring that urge can lead to absolutely brutal crashes.
  10. V.R.T.

    Trial Report Plasma cell targeting with the anti-CD38 antibody daratumumab in ME/CFS -a clinical pilot study, 2025, Fluge et al

    I maintain that pilot trials should have controls, even if that isn't 'how its done'. I think there would be less failed phase 2s if they did.
  11. V.R.T.

    Trial Report Plasma cell targeting with the anti-CD38 antibody daratumumab in ME/CFS -a clinical pilot study, 2025, Fluge et al

    The responses in the ritux pilot do not look like the dara ones - someone posted them in one of these threads the other day. They are not anything like as sustained or as large. In phase 2 ritux failed in its primary outcomes but they went ahead because of secondary stuff iirc. I'm not saying...
  12. V.R.T.

    Trial Report Plasma cell targeting with the anti-CD38 antibody daratumumab in ME/CFS -a clinical pilot study, 2025, Fluge et al

    I think we could debate this til the cows come home but I disagree.
  13. V.R.T.

    Trial Report Plasma cell targeting with the anti-CD38 antibody daratumumab in ME/CFS -a clinical pilot study, 2025, Fluge et al

    I mean that F&M should have included controls in the pilot. If none of the controls had had sustained improvements like the improvers who got the drug did, we could be a good deal more confident that the results are not placebo.
  14. V.R.T.

    Trial Report Plasma cell targeting with the anti-CD38 antibody daratumumab in ME/CFS -a clinical pilot study, 2025, Fluge et al

    Can you say anything about any more targeted projects you're aware of? All I can think of is the CA10 investigations that JEs pain colleagues are setting up.
  15. V.R.T.

    Multi-omics identifies lipid accumulation in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome cell lines: a case-control study, 2026, Missailidis et

    Exciting that you are uncovering other avenues! Are any of those projects written up/submitted or are they still ongoing?
  16. V.R.T.

    Trial Report Plasma cell targeting with the anti-CD38 antibody daratumumab in ME/CFS -a clinical pilot study, 2025, Fluge et al

    I think this should be standard. If F&M had done this with dara we'd be much further on by now.
  17. V.R.T.

    Trial Report Plasma cell targeting with the anti-CD38 antibody daratumumab in ME/CFS -a clinical pilot study, 2025, Fluge et al

    And that's also why I have so much hope riding on the dara trial, try as I might to not put too much hope into it
  18. V.R.T.

    Researchers looking specifically at PEM?

    I think @MelbME is doing a good day/bad day study? And @jnmaciuch has mentioned wanting to do a study where blood draws are done on patients currently in PEM. Apologies if I've got either of these wrong.
Back
Top Bottom